« Back to Record
Olympios, N., Lambertini, M., Calbrix, C., Saint-Ghislain, M., Fontanilles, M., Loeb, A., Leheurteur, M., Demeestere, I., Di Fiore, F., Perdrix, A., & Clatot, F. (2018). Impact of deleterious germline BRCA mutations, addition of taxanes and use of adjuvant endocrine therapy (ET) on anti-müllerian hormone (AMH) levels in early breast cancer (EBC) patients treated by adjuvant chemotherapy (CT). Poster session presented at ESMO (19-23/10/2018: Munich, Germany).
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/357159



